|
|
 |
|
Viewing report
|
|
|
|
MorphoSys AG: Premium Company Profile
Datamonitor, April 2008, Pages: 45
MorphoSys is a biotechnology company focused on the research and development of antibody drugs. The company’s main technology platform includes HuCAL (Human Combinatorial Antibody Library), an innovative technology which allows rapid and automated production of high-affinity antibodies.
Scope
- Contains corporate strategy, value chain presence and SWOT Analysis
- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
- Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights of this title
The company currently has therapeutic and research alliances with the majority of the world’s largest pharmaceutical companies including Boehringer Ingelheim, Centocor/Johnson & Johnson, Novartis, Pfizer and Roche.
Within these partnerships, more than 50 therapeutic antibody programs are ongoing in which MorphoSys participates through exclusive license and milestone payments as well as royalties on any end products.
MorphoSys derives its entire revenues from technology access fees and fees derived from research and development agreements primarily with companies such as Bayer, DuPont Pharmaceuticals, ImmunoGen, Hoffman La Roche and GPC Biotech.
Key reasons to purchase this title
- Access all the important information and analysis on the company in a single report
- Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
- Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Customers who bought this item also bought
MorphoSys AG
MorphoSys AG-Company Report
Hospira, Inc. Medical Equipment Company Report: Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
Viropharma Incorporated: Strategic Corporate Assessment - Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
Cubist Pharmaceuticals Inc: Strategic Corporate Assessment - Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
ABIOMED, Inc. Medical Equipment Company Report: Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
Premium Company Profile - Genmab
Premium Company Profile Celgene
Premium Company Profile - CuraGen
Premium Company Profile Medarex
Premium Company Profile Novavax
Ethicon, Inc. Medical Equipment Company Report: Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
|
|
|
|
